We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Novel Test Diagnoses Malaria in Returning Travelers

By LabMedica International staff writers
Posted on 07 Feb 2013
A novel, single-amplification polymerase chain reaction (PCR) assay has been used to diagnose malaria among travelers returning from endemic areas.

A practical single-round amplification Plasmodium-genus-specific PCR assays has been designed that is based on primers targeting the 18S locus and the mitochondrial genome with sensitivity and specificity equal to nested PCR.

Tropical disease specialists at the Haukeland University Hospital (Bergen, Norway) carried out a retrospective study of whole blood samples from a cohort of 132 fever patients with potential imported primary or recurrent malaria between 2006 and 2011. More...
The samples had been previously analyzed for malaria parasites on Giemsa-stained, thin and thick slides by experienced microscopists. Three PCR assays, two genus-specific and one species-specific, were assessed in the cohort of patient samples. The mitochondrial PCR products were sequenced in both directions.

Among the 135 samples assayed, 28 were defined as malaria positive by at least two of the methods among microscopy and the three different genus-specific PCR assays. The new mitochondrial PCR was 100% sensitive detecting all 28 positives. At the threshold dilution 0.5 parasites/µL, the sensitivity of the mitochondrial PCR was 97%, that of the single-round, 18S PCR was 93%, and the reference nested 18S was PCR 87%. Both single-round amplification assays identified all malaria positives diagnosed by nested PCR that had a sensitivity of 96%.

Sequencing of the genus-specific mitochondrial PCR products revealed different single nucleotide polymorphisms that allowed species identification of the 28 sequences with following distribution; 20 were Plasmodium falciparum, 6 were P. vivax, 1 was P. ovale, and 1 P. malariae. The microscopists had missed two infections detected by all PCR assays.

The authors concluded that the design of PCR programs with suitable parameters and optimization resulted in simpler and faster single-round amplification assays. Both the sensitivity and specificity of the novel mitochondrial PCR was 100% and proved equivalent to the reference nested PCR. Sequencing of genus-specific mitochondrial PCR products could be used for species determination. The study was published on January 22, 2013, in the Malaria Journal.

Related Links:

Haukeland University Hospital



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Nucleic Acid Purification Instrument
QIAsymphony Connect
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researchers developed a blood test that accurately distinguishes early-stage breast cancer from healthy controls and may outperform tissue biopsy in predicting recurrence risk (Image Credit: Adobe Stock)

Epigenetic Blood Test Detects Early Breast Cancer and Predicts Recurrence Risk

Breast cancer screening can reduce mortality, but early detection remains challenging when tumors are small or difficult to identify through imaging. Blood-based liquid biopsies offer a potential complementary... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.